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Abstract
Background: Few empirical studies of research utilisation have been conducted in low and middle
income countries. This paper explores how research information, in particular findings from randomised
controlled trials and systematic reviews, informed policy making and clinical guideline development for the
use of magnesium sulphate in the treatment of eclampsia and pre-eclampsia in South Africa.
Methods: A qualitative case-study approach was used to examine the policy process. This included a
literature review, a policy document review, a timeline of key events and the collection and analysis of 15
interviews with policy makers and academic clinicians involved in these policy processes and sampled using
a purposive approach. The data was analysed thematically and explored theoretically through the literature
on agenda setting and the policy making process.
Results: Prior to 1994 there was no national maternal care policy in South Africa. Consequently each
tertiary level institution developed its own care guidelines and these recommended a range of approaches
to the management of pre-eclampsia and eclampsia. The subsequent emergence of new national policies
for maternal care, including for the treatment of pre-eclampsia and eclampsia, was informed by evidence
from randomised controlled trials and systematic reviews. This outcome was influenced by a number of
factors. The change to a democratic government in the mid 1990s, and the health reforms that followed,
created opportunities for maternal health care policy development. The new government was open to
academic involvement in policy making and recruited academics from local networks into key policy
making positions in the National Department of Health. The local academic obstetric network, which
placed high value on evidence-based practice, brought these values into the policy process and was also
linked strongly to international evidence based medicine networks. Within this context of openness to
policy development, local researchers acted as policy entrepreneurs, bringing attention to priority health
issues, and to the use of research evidence in addressing these. This resulted in the new national maternity
care guidelines being informed by evidence from randomised controlled trials and recommending explicitly
the use of magnesium sulphate for the management of eclampsia.
Conclusion: Networks of researchers were important not only in using research information to shape
policy but also in placing issues on the policy agenda. A policy context which created a window of
opportunity for new research-informed policy development was also crucial.
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Research utilisation in policy making
The importance of basing health care decision making at
both a clinical and a policy level on the outcome of sound
research studies, rather than only on clinical experience
and pathophysiological understanding, is increasingly
being recognised [1,2]. Davies & Nutley [3] suggest that
this shift in approach to decision making has been
encouraged by the growth of evidence based medicine.
Proponents of this approach suggest that decisions at a
policy level about resource allocation ought to be made
on the basis of "what works"[4-6]. In turn they believe
that "what works" can be determined on the basis of
sound research evidence from the evaluation of health
care interventions, particularly that based on systematic
reviews of randomised controlled trials (RCTs) [1,2]. It is
argued that decisions made on the basis of such research
evidence can be not only cost saving [5], but also life sav-
ing [1].
Although the view that policies should be informed by
research is widespread, and the pool of evidence on which
to base decisions is growing, [1,2], none of these positive
factors have lead to the automatic uptake of research into
policy making [7]. The literature recognises that the rela-
tionship between knowledge production (research that
produces evidence) and knowledge utilisation (evidence
used in policy making, programme implementation, pro-
gramme design, etc.) is complex [6,8] with many impedi-
ments to the use of research in policy [9-11]. The process
of research utilisation in health care policy making has
therefore, in it itself, become an area of study [9,12] in an
attempt to find ways of increasing the uptake of research
findings.
Much of what has been written on the use of health care
research by policy makers and managers takes the form of
theory and opinion. However some empirical research in
this area has been conducted. Two recent systematic
reviews have synthesised findings from qualitative studies
of evidence use [9,12]. The first [9] focused on studies
with health policy makers while the second included both
health policy makers and health care managers [12]. A
summary of the findings from these reviews is presented
in Table 1.
While these reviews present the best evidence we have on
research use, they are limited by the empirical studies
available. Lavis et al [12] conclude that there is a paucity
of sound research in this field, arguing that the yield of
research is neither plentiful, rigorous (more than one data
collection method) nor consistent (in the factors identi-
fied across studies as influencing evidence use). This pau-
city of rigorous studies is particularly striking for low and
middle income countries (LMICs): Lavis et al [12] identi-
fied only one study from these settings out of seventeen
included in the review while Innvaer et al [9] found only
four LMIC studies from a total of twenty four. This is
despite the issue of research utilisation being particularly
pertinent in LMICs which face a scarcity of resources cou-
pled with a high disease burden. While research has iden-
tified effective and affordable interventions for many of
the key health problems in these countries, these are often
not implemented or are discarded in favour of unproven
interventions [13-16]. Maternal health in South Africa is
no exception to this. Numerous reports and papers have,
on the one hand, highlighted effective maternal health
interventions while, on the other, noted failures to imple-
ment these programmes in many settings [17-20].
The maternal health policy context in South Africa
South Africa's health system has been dramatically and
negatively impacted upon by its apartheid past [21].
Maternal health services, and other health services, have
suffered as a consequence [22]. Prior to the change of gov-
ernment in 1994, there was no single national maternal
health policy, let alone coordinated clinical protocols.
Instead, each institution decided upon its own protocols.
This situation changed with the transition to democracy
when the health of women and children was recognised as
a priority by the new government [22]. In the process of
transition, concerted attempts were made to transform the
health system overall and in particular to affect policy
reform [23].
The problem of eclampsia and pre-eclampsia in South 
Africa
Pre-eclampsia and eclampsia (see below) are important
causes of maternal and infant morbidity and mortality
globally. Over 63 000 women are estimated to die annu-
ally after eclamptic convulsions, with most of these deaths
occurring in low and middle income countries [24-26].
Hypertension in pregnancy also remains a leading cause
of maternal death in South Africa. In 1998 hypertension
in pregnancy was reported as the highest primary obstetric
cause of maternal death (23.2% n = 131), with eclampsia
accounting for the highest proportion (59% n = 58) of
deaths within this group [17]. Subsequent enquiries into
maternal deaths reported similar findings [18,27]. Hyper-
tension related deaths were surpassed only by non-preg-
nancy related infections (31.4%), amongst which death
from AIDS-related illness is included [17]. Hence hyper-
tension remains the leading direct primary obstetric cause
of maternal mortality [28].
Pre-eclampsia has been defined as a disorder of pregnancy
that involves multiple systems within the body. It is usu-
ally associated with raised blood pressure, or hyperten-
sion, and protein in the urine (proteinuria). The exact
cause of pre-eclampsia is not well understood. WhenPage 2 of 13
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neys, clotting system or brain. The placenta, that provides
nutrients to the baby, is also often involved, with an
increased risk of poor growth and early delivery for the
baby. Eclampsia – a potentially life threatening condition
– is the occurrence of a convulsion or fit during pregnancy
in association with pre-eclampsia. It may occur if pre-
eclampsia is not controlled [29].
Effective treatment for eclampsia and pre-eclampsia: The 
evidence
Research evidence offers a treatment solution to the high
maternal mortality rate of eclampsia. Two large multi-cen-
tre RCTs [19,30,31] and three systematic reviews
[32,29,33] have shown the effectiveness of magnesium
sulphate in treating eclampsia and pre-eclampsia. Con-
cerns have been expressed internationally, however, that
this evidence is not necessarily translated into policy and/
or practice [15,34,35]. Using the example of magnesium
sulphate, Garner et al [5] argue that while in 1995 [30] a
large trial showed that this drug was the most effective
Table 1: Factors identified as influencing research use: a comparison between the findings of this study and that of two earlier 
systematic reviews.*
Systematic review 1 [9] Systematic review 2 [12] This study
Interaction (or the lack of interaction) and 
trust between policy makers and researchers
Interaction between policy makers and 
researchers
Trust in the research and the researcher
An interactive relationship between policy 
makers and researchers in which the 
researchers are able to receive the evidence 
and interpret it for members of the 
bureaucracy
The timeliness, relevance and quality of the 
research
The quality, timing and timeliness of the 
research; and the perceived relevance of the 
research
The evidence being regarded as being of good 
quality and therefore trustworthy
Appropriate evidence available at the right 
time, in this case when a solution to the 
problem of the high maternal mortality rate 
was being sought
The inclusion of effectiveness data - -
The political environment including political 
(in)stability and community pressure
- A political environment that is conducive to 
policy making
The extent to which research confirmed 
existing policies
- -
Bureaucratic processes including power and 
budget struggles
Political and bureaucratic conflict A bureaucracy that is open to change rather 
than obstructive
The availability of research summaries with 
clear recommendations
Publishing findings in a manner that is accessible 
beyond a scientific audience
-
- The importance of management support -
- The skill and attitude of those receiving the 
research
-
- The existence of policy networks A functioning policy network that includes 
researchers, policy makers and bureaucrats
- - The evidence being received in the context of a 
positive attitude towards research utilisation, 
particularly with regard to evidence from 
randomised controlled trials and systematic 
reviews.
* For each review, and for this study, we have attempted to list each of the factors identified as influencing research uptake into policy making. 
Where similar factors were identified by each review/study, these are listed in the same row of the table. An empty cell indicates that the relevant 
review/study did not identify this factor as important.Page 3 of 13
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still being used in obstetric practices in one third of the
world.
Aim
This paper reports on a sub-study within a three country
study of research utilisation[36]. The paper explores the
actual and perceived utilisation of research information,
in particular findings from RCTs, in policy making and
clinical guideline development for the treatment of
eclampsia and pre-eclampsia in South Africa over the
period of 1970 to 2005. Treatment policy for these condi-
tions was selected as an example of maternal health care
policy development in which an effective, evidence-based
intervention was available that was, in some respects, eas-
ier to implement than other obstetric practice changes,
such as the active management of the third stage of
labour. Drawing on theoretical approaches to research uti-
lisation and policy making, the paper aims to contribute
to an empirical understanding of research utilisation in
the process of policy making in LMICs. There are several
reasons why the South African setting provided an ideal
opportunity to study a contemporary relationship
between policy making and research in a developing
country. Firstly, eclampsia and pre-eclampsia had been
identified as a national problem. Secondly, RCTs and sys-
tematic reviews had recently provided robust evidence of
an effective treatment. Thirdly, national maternal health
policy had recently been developed.
Theoretical and analytical approaches
The literature on research utilisation suggests an inherent
complexity in the process by which research is translated
(or not) into policy and management decisions [7,8]. For
example specific research may be turned to because of a
need to solve a particular problem, or policies may gradu-
ally be more reflective of research as policy makers
become influenced by the finding over time [37]. Within
the policy making process, policy makers adopt, adapt
and act on research [38]. They may use research evidence
instrumentally (directly), conceptually (indirectly) or
symbolically (as justification) [39]. Research can also be
used at different stages of the policy making process such
as prioritisation, development or implementation [40].
It has also been argued that research utilisation is influ-
enced by many contextual factors such as the social and
political environment in which policy making is taking
place [10,16,38,41]. Yet as Bowen and Zwi [38] suggest,
researchers may not take account of the broader context.
They argue that:
"The social and political context and the many forces
at work in the policy environment provide challenges
to integrating evidence into policy and practice.
Researchers often do not see or recognize these fac-
tors" [38](p. 0601).
Since research is only one factor influencing policy mak-
ing, we needed to explore the process of policy making as
a whole in order to understand the place of research. We
also wished to move beyond a simple description of
where and how research is utilised in policy making. To
do so we turned to the literature on the policy making
process. Two models, that of agenda setting in policy mak-
ing [42] and influences on the policy making process [40]
were used as lenses through which to understand our
data. We briefly describe these models below.
We firstly drew on the analytical framework developed by
Kingdon [42] and applied widely within the health
domain [23,43,44]. This framework was not developed
for the analysis of research utilisation specifically, but for
understanding how issues enter the policy agenda. King-
don [42] suggests that three 'streams' shape agenda setting
within governments and other institutions – the problem
stream, the policy stream and the stream of politics. These
streams, he argues, are largely unrelated to each other. In
the problem stream are those issues defined or perceived
by policy makers and other officials as priority problems.
In the politics stream are various stakeholders and interest
groups who put forward particular points of view. Finally,
the policy stream selects from problems and politics those
issues that will be shaped into policies, based on factors
such as acceptability and feasibility. However, these poli-
cies may not relate immediately to what are seen as key
problems within the problem stream. Policy change can
occur when the three streams merge, sometimes as a result
of the activities of advocates or policy entrepreneurs. This
Kingdon [42] calls a 'policy window', when either the
problem is so large or there is a change in the political
stream and policy entrepreneurs have the chance to
advance their proposals onto the policy agenda. We drew
on Kingdon's [42] framework to explore how maternal
health entered the policy agenda, leading to policy and
guideline formulation.
We also drew on a political science framework that distin-
guishes "three general categories of influence on the poli-
cymaking process" [40](p. 141). These categories of
influence include ideas – values, research etc.; interests –
actors with a vested interest in the policy and those who
will benefit from or be harmed by the policy; and institu-
tions – the policy legacies and characteristics of the policy.
In addition this framework highlights the importance of
events- occurrences such as a change of government or a
public health emergency that may influence opinions and
attitudes and may also open and close opportunities for
change. Within this framework, research is only one com-
ponent contributing to the ideas that influence policyPage 4 of 13
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which to retrospectively assess the weight of the influence
of research in policy making at a particular moment in
time, as compared with all of the other influences or fac-
tors operating at the same time. We utilised this frame-
work to understand the range of factors influencing policy
making for maternal health.
Methods
This study adopted a qualitative approach to understand
the phenomena under investigation as experienced by the
actors involved in it [45]. Exploring actors' own accounts
of their experiences enhances understanding of the proc-
esses, rather than simply the outcomes, of research utilisa-
tion. Given the complexity of the issues involved, a case-
study methodology was used to explore the topic [46].
Throughout we attempted to adopt a reflexive stance by
maintaining an awareness of our influence over the
research process and outcomes [47].
Data collection
The case study is built around a triangulation [48] of three
data collection methods: a review of the recent policies,
the development of a timeline and fifteen key informant
interviews with local researchers and policy makers. All of
these methods have been used in previous studies of the
utilisation of research information in health policy [7].
Policy Review
Copies of all contemporary national policies and guide-
lines were obtained from the National Department of
Health. These were reviewed with the aim of establishing
the extent to which research information had been implic-
itly and explicitly used [40]. This was done through check-
ing the references of each policy and the extent to which
the use of research information was mentioned. Whether
or not the policy recommended magnesium sulphate for
the treatment of eclampsia and pre-eclampsia was also
noted.
Timeline
A timeline of key events in the management of eclampsia
and pre-eclampsia in South Africa was constructed itera-
tively. During each interview respondents were asked to
comment on or add to the timeline. It was also shared
with colleagues and any further information was incorpo-
rated. Relevant bibliographical and conference databases,
as well as the websites of organisations such as the
National Department of Health in South Africa and the
Cochrane Collaboration, provided additional informa-
tion.
Interviews
Between 2004 and 2005 individual qualitative interviews
were conducted by KD and SL with fifteen local research-
ers and government officials (past and present). These
interviews were audio recorded and then transcribed ver-
batim. Neither of the interviewers were known among
respondents as an advocate of evidence-based medicine.
The interviews were structured around a flexible interview
schedule designed collectively by the broader research
team to address all facets of the research question. Each
interview broadly covered the following topics: the
respondent's background; their knowledge of national
policies; their knowledge of and involvement in the policy
development process; their understanding of the various
influences on the policy process and content including
stakeholder involvement, prevailing values and research
information. The respondents were purposively sampled
on the basis of being influential and/or knowledgeable in
the process of policy making and guideline development
for maternal health, and included both obstetricians and
midwives. They were identified through colleagues work-
ing in the field and using a 'snowballing' approach [49].
Within this process attention was given to fair dealing and
seeking out negative cases [47]. During the course of our
data collection it became clear that we were interviewing
people who shared similar opinions regarding the use of
research evidence in the maternal health policy process. In
fact one respondent referred to there being a "club" within
the obstetric community. We therefore actively sought
respondents who might have held differing views. How-
ever we only identified one such individual.
Our respondents had all been trained in either midwifery
(4) or obstetrics and gynaecology (11). They were all
either active in the policy and guideline development
process or were very knowledgeable about this area. Four
respondents were currently or formally employed by the
National Department of Health. One respondent was a
practising midwife and nursing tutor. The other eight were
academic researchers (professors and associate profes-
sors). One respondent had held a senior position both in
the national department and as an academic researcher
and was able therefore to reflect on the research question
from both perspectives.
In reporting on our findings below, we use the abbrevia-
tion 'DoH' to indicate data extracts from interviews with
current or former staff of the National Department of
Health. The abbreviation 'Acad' indicates extracts from
academic researchers. The number after the abbreviation
indicates the respondent number in each group.
Analysis
A thematic content analysis of the verbatim transcripts
was conducted [50]. The process was led by KD, super-
vised by SL and internally validated by the wider three
country research team. After immersion in the transcripts,
these were coded for both latent and manifest themesPage 5 of 13
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pasted into a Word document, which was shared and
checked between KD and SL. Out of this process a narra-
tive account of the data was written up as the key research
findings, some of which are presented here. The findings
are illustrated further by data extracts selected on the basis
of being representative and/or interesting illustrations of
each of the themes [52]. Although our analysis was prima-
rily inductive, we drew on several analytic frameworks
from the policy literature to better understand how
research evidence informed policy-making in this context,
as described above.
Ethical issues
The main study [36] received approval from ethics com-
mittees at the Medical Research Council of South Africa,
the London School of Hygiene and Tropical Medicine, the
University of Zimbabwe, Eduardo Mondlane University
and the World Health Organisation. This sub-study also
received approval from the ethics committee chairperson
at the University of Cape Town.
All participants in the study signed a consent form after
being given a written study information sheet and a verbal
explanation of the consenting process.
Findings
Research utilisation in contemporary maternal health 
policies and guidelines: a document review
Since 1994 the following relevant guidelines for maternal
care, including the management of eclampsia and pre-
eclampsia, have been produced:
• Guidelines for Maternity Care in South Africa: A manual for
clinics, community health centres and district hospitals, (2000
& 2002)[53]
• Saving Mothers: Policy and Management Guidelines for
Common Causes of Maternal Deaths, (2001) [54]
• Saving Mothers: Second Report on Confidential Enquiries
into Maternal Deaths in South Africa, 1999–2001,
(2002)[18]
The first set of guidelines (Maternity Care), were general-
ised and aimed at primary care practioners. In contrast the
second set (Saving Mothers) was specific to the treatment
of priority maternal health problems as identified by the
Confidential Enquiries. Furthermore, the "Saving Moth-
ers" guidelines were aimed at all levels of care including
tertiary care.
These documents are very different in the manner in
which they reflect their use of research evidence. Both edi-
tions of the "Guidelines for Maternity Care" include in
their introduction a statement reading:
"The guidelines are based on the best available evi-
dence from published research, modified where neces-
sary to suit local conditions. References are not given,
but are available from the authors on request. Specifics
of management and drug dosing are not cast in stone,
and can be modified according to the experience of the
reader and new evidence". (p. 8 in both editions)
They also both refer to the Cochrane Library as a site for
further reading. In other words, although the guidelines
claim to be based on evidence, it is left to the person read-
ing the guidelines to verify if they so wish. The two docu-
ments suggest the use of evidence, but the nature of this
use is not made explicit. In the guidelines themselves,
though, magnesium sulphate is the only drug recom-
mended for the treatment of severe eclampsia, imminent
eclampsia and eclampsia. Guidelines for its administra-
tion are provided.
The two "Saving Mothers" documents are far more explicit
in their use of research evidence. The "Policy and Manage-
ment Guidelines" (2001) notes that it is "customary to
grade the evidence, on which clinical statements are
based, according to the strength of such evidence" (p. 5).
The document then goes on to explain the grading levels,
e.g. "Grade A Evidence from randomised controlled tri-
als". Within each guideline section full references to the
study from which each specific recommendation is
drawn, and the grade of the evidence is given, for example:
"Magnesium sulphate is the best drug to arrest and
prevent further convulsions Grade A evidence. (The
Eclampsia Collaborative Group. Lancet 1995;
345:1455–63)" (p. 28)
The policy document review therefore showed very con-
crete and explicit examples of research utilisation in policy
making and guideline development. It also shows the
strengthening of the use of research evidence in policy
documents over time. The interview and historical data
presented below explain the process through which these
policies came about.
Policy making for maternal care in South Africa
• Filling a policy vacuum and standardising national care
There was no national policy or management guideline
for maternal care until the publication of the 'Guidelines
for Maternity Care in South Africa' in 2000, followed by
the 'Saving Mothers Policy and Management Guidelines
for Common Causes of Maternal Deaths' in 2001. Prior to
this, as respondents explained, the obstetric departments
of the various medical universities around the countryPage 6 of 13
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be used at hospitals and maternity services attached to
these institutions. As one respondent argued, these insti-
tutions tended to pursue "their own identities even in
terms of protocol" (DoH 2). Both nursing and medical
students were taught practices that followed the protocol
of the training institution in which they were enrolled.
Consequently, there was no standardisation of practice
across the country, causing difficulties when health pro-
fessionals from different practice backgrounds had to
work together in one setting:
"So this [national policy] then starts saying, 'This is
what is accepted as practice in South Africa'. So that
even if you come from [the University of] Cape Town
and you decide you're going to give 20 drops, and
another one comes from Medunsa [the Medical Uni-
versity of South Africa] and say we give 30 drops, then
[the policy] will say: 'These are the drops that you must
give'. So that the nurse, who is working with the doc-
tor, knows that this is what has to be done. Not to be
shouted at because she's running with 25 drops and at
Medunsa they say 'not giving enough', [while] Cape
Town says this: 'You're giving more than enough'... "
(DoH 2)
This lack of national standardisation was compounded in
some settings by foreign doctors using yet further proto-
cols developed in their own countries.
The structure of the South African health system means
that medical specialists are often situated only in urban
tertiary hospitals, thus not reaching all women in need of
specialist care. Our respondents indicated that one inten-
tion of the guidelines was to expand care by allowing for
midwives and doctors who had not received specialist
training, and specialists who had not trained within the
country, to all be able to deliver care of a similar quality to
that that might be provided by a specialist (DoH 1). Fur-
thermore, they suggested that the guidelines were also
intended, through the involvement of academics in their
writing and reviewing, to influence the training of health
care providers across the country. We discuss this in more
detail below.
• A change in direction for national maternal health care
Our interview data suggested that the change in govern-
ment in South Africa in 1994 was a crucial watershed for
policy development. As shown in the timeline (Table 2),
the national policies and guidelines for maternal care
were published six and seven years after the first demo-
Table 2: An abbreviated timeline of key events
Date Key Events in
The evolution of policy and guidelines for the treatment of eclampsia and pre-eclampsia in South Africa
1955 First Pritchard case series published, showing effectiveness of MgSO4. Updated every 10 years until 1984
1968 British physicians in Hong Kong suggest use of diazepam
1970's MgSO4 introduced into obstetric care at key medical faculties in South Africa
1979 Obstetrics criticised by Archie Cochrane as being least evidence based medical speciality
1980's Use of MgSO4 spreads through teaching and inter-institutional contact between academics. International divisions on the choice 
of anti-convulsant are reflected in the country
1980's-90's South African researchers become increasingly connected to the international obstetric research community and simultaneously 
the local research output increases
Although provinces and institutions have their own policies there are no national policies or guidelines
By early 1990's MgSO4 in widespread use in SA for treating eclampsia
1990 Randomised controlled trial, of MgSO4 vs phenytoin for eclampsia conducted in South Africa published in British Journal of 
Obstetrics and Gynaecology 1990 Feb; 97 (2): 104–9.
1992 Pregnancy and Childbirth Group, first Cochrane Review Group to be registered
1993–95 South African researchers collaborate in Eclampsia Trial at local trial sites
1994 Change of government promotes new focus on maternal health and openness to academic involvement in policy making
1995 Collaborative Eclampsia Trial published
1995 Senior obstetricians in South Africa publish editorial on implications of Collaborative Eclampsia Trial
1996 Maternal health organised into a separate directorate within national DoH
Academic advocacy for maternal mortality monitoring followed by the appointment of the first National Committee for 
Confidential Enquiry into Maternal Deaths (NCCEMD)
1999 First NCCEMD report published. Eclampsia accounts for highest percentage of the deaths due to hypertensive disorders of 
pregnancy, which is the second largest cause of maternal deaths. National policy and guidelines recommended.
2000 First national "Guidelines Maternity Care" published. Evidence is referred to but not referenced
2001 NCCEMD publishes policy and management guidelines for common causes of maternal deaths. MgSO4 recommended and use of evidence 
made explicit.
South African researchers collaborate in Magpie Trial at local sites. South Africa is the regional trial co-ordinating centre.
2002 Magpie Trial published
2003 Following on from trial, MgSO4 is recommended for women with moderate to severe pre-eclampsia, where it can be 
administered safely, in South African Medical Journal.Page 7 of 13
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respondents as an aspect of democratic reform, with poli-
cies being formulated throughout health care, not just for
maternal care, as has also been noted elsewhere [23]. One
respondent (Acad 7) suggested that the change in govern-
ment ushered in a new openness to discussions between
researchers and government regarding maternal health
and other policies. New staff employed by the National
Department of Health were seen by several respondents as
having different values to those who had been there
before. For example, one respondent suggested that
record keeping under the previous government was
designed to hide the health problems of the poor, but that
the new cohort of people employed in the department
had experienced these problems personally and wanted to
correct them. These respondents, who had been employed
in the National Department during this phase, spoke of
wanting to improve health for all:
"So there was a need to then say it was one country,
and therefore, we need to reform this [country] and we
need to have policies that respect everyone irrespective
of race, colour or creed. So I think that is the one
aspect. I think also the fact that many of the people
who then came into government, came from under-
privileged communities. So it was important and nec-
essary to try and change the conditions of those
communities." (DoH 2)
• Influence and values of a small academic obstetric network
Following the shift in values regarding the delivery of
health care, professional networks in South Africa, includ-
ing the South African Society of Obstetrics and Gynaecol-
ogy, the College of Medicine and the Priorities in Peri-
Natal Care Conferences, were influential in placing mater-
nal health on the policy agenda. The new cohort of staff,
appointed into key positions within the Directorate of
Maternal and Child Health within the National Depart-
ment of Health, had long standing links with these net-
works. In addition, respondents described how a small
group of researchers involved closely in these networks
were able to convince the National Department, and in
particular the incoming Minister of Health (Dlamini-
Zuma), of the need to make maternal death notifiable so
as to allow the extent of the problem and its causes to be
explored systematically. This group lobbied for the assess-
ment of the leading causes of mortality through a confi-
dential enquiry into maternal death. Thus in 1996 the first
National Committee for the Confidential Enquiry into
Maternal Death was appointed, chaired by Prof. Jack
Moodley, a leading figure within national obstetric net-
works. Respondents described the outcome of this
enquiry as particularly significant for policy development
with regard to the management of eclampsia. Firstly, the
first Confidential Enquiry found that hypertension was
the leading cause of maternal mortality (prior to the esca-
lation in AIDS related deaths). Secondly, it recommended
that a national policy be written. Following from this, the
National Department began drafting the 'Guidelines for
Maternity Care in South Africa' in 1998. At the launch of
the first report of the Confidential Enquiry, members of
the College of Medicine volunteered to write clinical man-
agement guidelines for the treatment of the ten most com-
mon causes of maternal death. Thus two national policies
were published within a year of each other.
The importance of this obstetric network, though, was not
only their influence in bringing attention to the need for
maternal care policies and their willingness to assist in
developing these, but also the values that they brought to
this development process. Beyond regular local contact,
key members of this group were also tied into interna-
tional networks for the promotion of evidence based
medicine, such as the Cochrane Collaboration and the
National Perinatal Epidemiology Unit in Oxford. One
respondent described the close links between the South
African researchers and these international evidence-
based practice networks:
"We actually invited Murray Enken, who was attached
to the Oxford Database [of Perinatal Trials]. And sub-
sequent to that Iain Chalmers, who's the editor, was
invited to attend [the annual Priorities in Perinatal
Care conference]. So we were sort of, I think from the
word go, when the Oxford Database became available
for use, we were part of it, we were aware of it, we were
using it, and I think quite a few South Africans became
involved on their editorial board and as editors or
reviewers, or whatever." (Acad 1)
Within this network of South Africa researchers, the con-
cept of evidence based medicine had been diffused exten-
sively:
"No, it [the clinical maternity care guidelines] was
purely evidence based. We really tried to be as scien-
tific as possible... the Oxford database was used very
extensively, and subsequent to that the Cochrane data-
base. So we tried to stick as close as possible to evi-
dence-based medicine and not sort of traditional ways
and means of dealing with things, but really to make
it, have it scientifically founded." (Acad 1)
"At that stage, I was a member of the society [of obste-
tricians and gynaecologists] and attended all their con-
gresses, and I was director of [a] ...research unit... So of
course, you wanted to do the best practice. You
wanted to use the best protocols. You wanted to do
evidence based medicine." (Acad 6)Page 8 of 13
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available research evidence was strongly held. Best evi-
dence was understood to be that which was derived from
randomised controlled trials and systematic reviews:
"And if you look at the proceedings of the first couple
of [perinatal priorities] conferences, most of the stud-
ies were epidemiological studies, and then you'll see, I
think from the early 80s onwards, the move towards
more and more randomized trials and systematic
reviews were being presented. And I think it was really
the influence of the Oxford database of peri-natal tri-
als which got us all thinking in that way." (Acad 3)
Collaborating closely, sharing many of the same ideas and
having "members" now placed within the National
Department of Health meant that this group influenced
strongly the final policies and guidelines which were pro-
duced for maternal care as well as the use of evidence
within these guidelines.
Giving credibility to the policies
Respondents described how the use of research evidence
was seen to lend credibility to the maternal care policies
among important stakeholder groups. For example, a
respondent responsible for the first draft of the 'Guide-
lines for Maternity Care' saw the use of evidence as not
just a reflection of the values of the National Department
of Health, but also of the "world that we live in" and the
country. He explains:
"But I mean, in the world we live today, it is the world
of evidence based practice, evidence based medicine.
So one had to be careful about... cognizant of the fact
that one had to use the best available evidence.
Because I mean, this would be national... it would be
a reflection of us as a country." (DoH 3)
He also noted how, as a consequence of his obstetrics
training, evidence based medicine was "the truth I knew –
that's how I was cultured" (DoH 3). In the face of a strong
obstetric fraternity who were steeped in a culture of evi-
dence based medicine, the National Department therefore
had to produce guidelines that would have credibility and
withstand scrutiny, as one of their officials describes:
"As I indicated...the aim of maternal and child health
at national is to improve the health of women and
children, and for anything to be used, especially if you
include academics and everybody, for anything to be
utilised, then people want to be convinced that this
actually is [of] benefit and it can work. So you then
need to have evidence. If you come and say that mag-
nesium sulphate works to stop eclampsia and to fur-
ther prevent people from fitting, you see people will
say, 'Where do you get that from?' And you cannot say,
'I heard somebody saying it works'. You need evidence
and, therefore, you have then to rely on the research
that has been done. And without that information it
would be very difficult to convince anybody to actu-
ally buy into what you are doing." (DoH 1)
Research evidence was seen by these respondents to have
given power and credibility to these policies. The authors
of the policies were keenly aware of the social context in
which these policies were written. They used evidence not
only because they believed that it offered the best possible
treatment solution, but also because they believed that
those reading the policies would be more convinced of
the strength of recommendations if they were obviously
supported by systematically gathered research evidence.
Discussion
Since as early as the 1970s [37]analysts and researchers
have been suggesting that the process of research utilisa-
tion is complex and politically fraught. Yet our findings
could be seen as indicating a very neat assimilation of evi-
dence into policies and clinical guidelines. Following the
publication in 1995 of the results of the Collaborative
Eclampsia Trial, its recommendations were adopted with-
out change into South African maternal health care policy
in order to address maternal mortality. The evidence was
therefore used in an instrumental manner [7,9,38,39].
This seemingly linear assimilation of research findings
into policy fits neatly within the knowledge driven model
of research utilisation in which information from research
is utilised because it exists [37,38]. To explain how this
came about we need to look more closely at the policy
process in which this research evidence was utilised. This
suggests that the use of evidence was perhaps less linear
than the knowledge driven model suggests and highlights
the place of research networks and policy context in
research utilisation.
Getting maternal health care onto the South African 
policy making agenda
Drawing on Kingdon's framework [42], our findings sug-
gest that maternal health researchers in South African
acted as policy entrepreneurs in order to place issues on
the government's policy agenda. Prior to the change of
government in 1994, little attention was given to maternal
health at a national level and there were no national pol-
icies in this area. This was despite ongoing attempts by
advocates, some of whom were respondents in this study,
to bring the problem of maternal health to the attention
of national government. As already noted, these advocates
were involved in national and international research net-
works for improving maternal health. They recognised the
problem of poor maternal health outcomes in South
Africa; they believed that there were potential solutions toPage 9 of 13
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government attention to this.
The political climate prior to 1994 did not, however,
allow these policy entrepreneurs to gain the attention of
the national government in a way that would effect mean-
ingful policy changes. This climate changed dramatically
when, in 1994, South Africa held its first democratic elec-
tions and a new national administration came into being.
Following this change the National Department of Health
employed a new cohort of health officials. Appointed to
key positions were people with strong links to the net-
works of policy entrepreneurs and researchers who collec-
tively sought a change in the approach to maternal health.
These new government employees created a space in
which these policy entrepreneurs could engage with the
National Department of Health. As a result of their con-
tinued advocacy and the new openness in government, a
decision was made to conduct a national confidential
enquiry into maternal mortality. This enquiry established
that maternal mortality was a problem and recommended
that a national policy for maternal health be formulated.
Only once the need for a national maternal health care
policy was expressed did opportunities arise for drawing
research evidence into that policy.
Understanding the policy making process for maternal 
health in South Africa
In the context of this new drive to formulate policies, why
was evidence from RCTs and systematic reviews used?
Understanding the influences on policy making [40] may
help us to better understand this. As alluded to above, a
key event preceding the writing of the 'Guidelines to
Maternity Care' was the election in 1994, which brought
in a new dispensation. At an institutional level, the South
African Constitution now recognised the right to health
services with attention to the needs of women and chil-
dren [55]. The government also prioritised women's
health care in the process of reforming the National
Department of Health. An important subsequent event
was the first Confidential Enquiry into Maternal Deaths,
the findings of which supported calls for new maternal
health policies. An idea held very strongly by those
charged with the responsibility for writing these policies
was that these should be based on the best available scien-
tific evidence. This was believed to be the results of sys-
tematic reviews and randomised controlled trials.
Fortuitously, a randomised controlled trial showing the
effectiveness of magnesium sulphate for the treatment of
eclampsia was published during the period that evidence
was being sought to develop policies for the management
of this condition [30]. A number of key academic obstetri-
cians in South Africa had been involved in the study,
which raised its profile and gave it higher credibility
within the country. Furthermore, interest groups in the
new government wanted to be seen to be keeping abreast
of international health care trends, including that of bas-
ing policies on rigorous scientific evidence.
Understanding the influences on policy suggests that the
process of research utilisation observed in this study was
more complex than first meets the eye. Although the
results of the Collaborative Eclampsia Trial were pub-
lished only a few years before the "Guideline for Maternity
Care" was developed [30], the availability of this evidence
was not sufficient to ensure its uptake automatically. Our
analysis suggests that this evidence was received in a con-
text which was open to research utilisation – when those
developing policies and guidelines wanted to offer the
best possible care to women. The three key categories of
influence on the policymaking process – ideas, interests
and institutions – were therefore in alignment, facilitating
the uptake of evidence into policy making.
Our findings also highlight the interdependency of these
influences on each other and the uncertain nature of the
policy and guideline making process. Policies for mater-
nal health could well have been formulated differently if
the key interest groups had held a different set of values.
This suggests, firstly, that networks of influence are very
important and, secondly, that research utilisation can be
unpredictable if dependent on the values of these net-
works. Our findings also confirm the importance of con-
text to research utilisation [38]. The difficulty for those
wishing to influence research utilisation is that they may
not always have the power or authority to influence this
context. Researchers may not be able to influence events
to create windows of opportunity. However, researchers
can ensure that high quality evidence is produced and is
accessible to policy makers. They can also organise them-
selves into networks in order to enhance their influence
and be willing to act as policy entrepreneurs when the
opportunity arises. While the event of the South African
change in government may be unique, we believe that
opportunities for change in policy (policy windows)
present themselves in most settings, for example when
elections bring in a new government or when there is a
change of health minister or senior health department
officials. As Kingdon [42] suggests, policy entrepreneurs
need to be attentive to when key policy influences are in
alignment and when a window of opportunity opens for
policy change.
Placing the study findings in context
This study contributes to the limited body of empirical
work from LMICs on the factors influencing the uptake of
research into policy making [9,12]. Our study findings are
consistent with those of two earlier systematic reviews
[12,9] of studies in this field (see Table 1). It is also worth
noting that our findings are likely to be time and contextPage 10 of 13
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dependent on the change of government in 1994 and on
the consequent reshaping of the policy environment.
Limitations of the study
In exploring the role of research evidence in policy mak-
ing, this study has several limitations. Firstly, it draws
heavily on the accounts of respondents. A strength of this
approach is that the data represents the views of those
closely involved in formulating the policies studied and
therefore provide valuable insights into policy processes.
The interviews also provide a thick description of research
utilisation processes allowing us to situate these within
their wider context. This enhanced what we learnt from
the experience of others. However, we recognise that such
accounts are inevitably influenced by respondents' posi-
tion at time of event; their position at the time of being
interviewed; their relationship with the researchers; the
shifts that they may have made over time between organ-
isations; and their memory of particular events [43].
Secondly, the snowballing approach used to select
respondents can yield a sample of people who share sim-
ilar opinions. To avoid this, we actively sought respond-
ents with differing views and explored negative cases [47].
Thirdly, this study did not address policy implementa-
tion, rather focusing on policy development. It is likely
that resource limitations, which are often more pro-
nounced in LMIC settings, are more important barriers to
the implementation of evidence based policies than to the
prior use of evidence in policy and guideline develop-
ment. Further studies are required to explore the how pol-
icies for maternal health have been implemented in South
Africa.
Fourth, as this is only one case study, the findings need to
be generalised to other contexts and health issues with
caution. As a treatment, magnesium suphate is perhaps
less complex in its implementation than certain other
obstetric interventions, such as the provision of emo-
tional support during labour. However it is striking that
many of our findings reflect those of the systematic
reviews discussed earlier. Furthermore, this is not the only
example of evidence being applied to treatment policy in
South Africa. In a similar example of linear research utili-
sation, evidence for the effectiveness of artemisinin-based
combination therapy in the treatment of uncomplicated
Plasmodium falciparum malaria was used to change malaria
treatment policy in the KwaZulu-Natal province [56].
Although the case study approach, like many qualitative
methods, has been critiqued for having limited generalis-
ability [57], we would argue that the approach allows the-
oretical generalisability [52] and also provides insights
into the ways in which knowledge informs policy making
in 'real life' contexts [58]. The transferability of the find-
ings reported here will also be enhanced when considered
alongside those from the other five cases, which contrib-
ute to the main study [36].
Conclusion
This study provides an example of the direct use of
research evidence in the development of maternal health
policies and guidelines. However, we would also argue
that the use of research findings in this case had symbolic
value, indicating to the potential users of the policies and
to other actors that South Africa was part of the broader
international movement to base clinical policies and prac-
tice on high quality research evidence. In this and a
number of other ways, this study illustrates how policies
are shaped by the national and international contexts in
which they are developed. The impact of context is further
highlighted by the finding that the uptake of RCT evi-
dence on the effectiveness of magnesium sulphate in treat-
ing eclampsia into clinical policies was facilitated by the
opening of a window of opportunity, following the
change of government in South Africa in 1994. This win-
dow allowed a network of researchers to place maternal
health on the agenda of policy makers. This study there-
fore also indicates the ways in which researchers may not
only influence the content of policies and guidelines but
also, through acting as policy entrepreneurs, shape policy
agendas [42]. We would not, however, wish to overstate
the role of research evidence in driving policy develop-
ment for maternal health in South Africa. As we have dis-
cussed, such evidence was just one of a constellation of
factors influencing this process (see Table 1) and it was
certainly serendipitous that an important international
RCT, in which a number of key South African researchers
had participated, was published shortly before policies for
the management of eclampsia were developed. Nonethe-
less, the close links between the research and policy arenas
were central to the emergence of evidence based policies
for maternal health in South Africa.
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